Sumit Gupta remains positive on Cipla and Sun Pharma amid strong US generic market performance
So, within the generic companies, from the US point of view, Cipla delivered a very good set of results supported by the ...
Hosted on MSN2mon
Which pharma companies will benefit from latest government policies? Sumit Gupta explains
Sumit Gupta, AVP-Research, Centrum Broking, says the government is providing a push towards manufacturing and R&D. Indian pharma has technical know-how. Now, the government wants to do technical ...